OS10.6 Infigratinib (BGJ398) in patients with recurrent gliomas with fibroblast growth factor receptor (FGFR) alterations: a multicenter phase II studyAndrew B. Lassman, Patrick Roth, Vinay K. Puduvalli et al.|Neuro-Oncology|2019Cited by 11
ACTR-33. INFIGRATINIB (BGJ398) IN PATIENTS WITH RECURRENT GLIOMAS WITH FIBROBLAST GROWTH FACTOR RECEPTOR (FGFR) ALTERATIONS: A MULTICENTER PHASE II STUDYAndrew B. Lassman, Patrick Roth, Juan Manuel Sepúlveda-Sánchez et al.|Neuro-Oncology|2019Cited by 8